Drug Type Chemical drugs |
Synonyms TAGX 0003 |
Target |
Action inhibitors |
Mechanism IFNγ inhibitors(Interferon gamma inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dry Eye Syndromes | Preclinical | Japan | 01 Nov 2023 |